Abstract
Purpose
To compare growth factor and cytokine profiles in the endometrial secretions of patients with and without endometriosis to determine whether a particular protein profile is predictive of the disease.
Methods
Patients undergoing laparoscopic gynecologic surgery for benign indications were recruited for this prospective cohort study. Prior to surgery, endometrial fluid was aspirated and multiplex immunoassay was used to quantify 7 cytokines and growth factors. During surgery, each patient was staged according to the ASRM staging system for endometriosis. Cytokines and growth factors were evaluated using the Mann-Whitney and Kruskal-Wallis tests. Combinations of cytokines were evaluated using logistic regression analysis, and ROC curves were generated to evaluate the predictive capacity of the assay.
Results
Endometrial secretions were analyzed from 60 patients. Nineteen had stage 3–4 endometriosis, 19 had stage 1–2 disease, and 22 had no endometriosis. There were no significant differences between controls and stage 1–2 endometriosis; however, levels of IL-1α and IL-6 were significantly increased in women with moderate-to-severe disease. A combination of IL-1α, IL-1β, and IL-6 in endometrial secretions predicts stage 3–4 endometriosis with an AUC of 0.78. A threshold value of 118 pg/mL yields a sensitivity of 75% and specificity of 70%.
Conclusion
Aspiration of endometrial fluid is a safe and effective approach for evaluating the endometrial profile of women with endometriosis. Women with moderate-to-severe endometriosis demonstrate a distinct cytokine profile compared to controls. A combination of IL-1α, IL-1β, and IL-6 in the endometrial secretions is predictive of stage 3–4 endometriosis, but is not predictive of minimal-to-mild disease.
Similar content being viewed by others
References
Mahmood TA, Templeton A. Prevalence and genesis of endometriosis. Hum Reprod. 1991;6(4):544–9.
Cramer DW, Missmer SA. The epidemiology of endometriosis. Ann N Y Acad Sci. 2002;955:11–22.
Vigano P, Parazzini F, Somigliana E, Vercellini P. Endometriosis: epidemiology and aetiological factors. Best Pract Res Clin Obstet Gynaecol. 2004;18(2):177–200.
Greene R, Stratton P, Cleary SD, Lou Ballweg M, Sinaii N. Diagnostic experience among 4,334 women reporting surgically diagnosed endometriosis. Fertil Steril. 2009;91(1):32–9.
Nisenblat V, Bossuyt PM, Shaikh R, Farquhar C, Jordan V, Scheffers CS, Mol BW, Johnson N, Hull ML. Blood biomarkers for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev. 2016;2016(5):CD012179.
Liu E, Nisenblat V, Farquhar C, Fraser I, Bossuyt PM, Johnson N, Hull M. Urinary biomarkers for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev. 2015;2015(12):CD012019.
Gupta D, Hull ML, Fraser I, Miller L, Bossuyt PM, Johnson N, Nisenblat V. Endometrial biomarkers for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev. 2016;4(4):CD012165.
Ulukus M, Cakmak H, Arici A. The role of endometrium in endometriosis. J Soc Gynecol Investig. 2006;13(7):467–76.
Boomsma CM, Kavelaars A, Eijkemans MJC, Lentjes EG, Fauser BCJM, Heijnen CJ, Macklon NS. Endometrial secretion analysis identifies a cytokine profile predictive of pregnancy in IVF. Hum Reprod. 2009;24(6):1427–35.
Boomsma CM, Kavelaars A, Eijkemans MJC, Amarouchi K, Teklenburg G, Gutknecht D, et al. Cytokine profiling in endometrial secretions: a non-invasive window on endometrial receptivity. Reprod BioMed Online. 2009;18:85–94.
Ametzazurra A, Matorras R, Garcia-Velasco JA, Prieto B, Gonzalez S, Simon L, Nagore D. Validation of endometriosis markers in the endometrial fluid aspirate. Hum Reprod. 2009;24(suppl_1):i9–i11.
Ametzazurra A, Matorras R, Garcia-Velasco JA, Prieto B, Simon L, Martinez A, Nagore D. Endometrial fluid is a specific and non-invasive biological sample for protein biomarker identification in endometriosis. Hum Reprod. 2009;24(4):954–65.
Podgaec S, Abrao MS, Dias JA, Rizzo LV, de Oliveira RM, Baracat EC. Endometriosis: an inflammatory disease with a Th2 immune response component. Hum Reprod. 2007;22(5):1373–9.
Othman EEDR, Hornung D, Salem HT, Khalifa EA, El-Metwally TH, Al-Hendy A. Serum cytokines as biomarkers for nonsurgical prediction of endometriosis. Eur J Obstet Gynecol Reprod Biol. 2008;137(2):240–6.
Mier-Cabrera J, Jiménez-Zamudio L, García-Latorre E, Cruz-Orozco O, Hernández-Guerrero C. Quantitative and qualitative peritoneal immune profiles, T-cell apoptosis and oxidative stress-associated characteristics in women with minimal and mild endometriosis. BJOG. 2011;118(1):6–16.
Bersinger NA, Dechaud H, McKinnon B, Mueller MD. Analysis of cytokines in the peritoneal fluid of endometriosis patients as a function of the menstrual cycle stage using the Bio-Plex® platform. Arch Physiol Biochem. 2012;118(4):210–8.
Vodolazkaia A, El-Aalamat Y, Popovic D, MihalyiA, Bossuyt X, Kyama CM, Fassbender A, BokorA, Schols D, Huskens D, Meuleman C, Peeraer K, Tomassetti C, Gevaert O, Waelkens E, Kasran A, De Moor B, D’Hooghe TM. Evaluation of a panel of 28 biomarkers for the non-invasive diagnosis of endometriosis. Hum Reprod. 2012;27(9):2698–711.
Wickiewicz D, Chrobak A, Gmyrek GB, Halbersztadt A, Gabryś MS, Goluda M, Chełmońska-Soyta A. Diagnostic accuracy of interleukin-6 levels in peritoneal fluid for detection of endometriosis. Arch Gynecol Obstet. 2013;288(4):805–14.
Beste MT, Pfaffle-Doyle N, Prentice EA, Morris S, Lauffenburger DA, Isaacson KB, Griffit LG. Endometriosis: molecular network analysis of endometriosis reveals a role for c-Jun-regulated macrophage activation. Sci Transl Med. 2014;6(222):222ra16.
Borrelli GM, Kaufmann AM, Abrão MS, Mechsner S. Addition of MCP-1 and MIP-3β to the IL-8 appraisal in peritoneal fluid enhances the probability of identifying women with endometriosis. J Reprod Immunol. 2015;109:66–73.
Kocbek V, Vouk K, Bersinger NA, Mueller MD, Rižner TL. Panels of cytokines and other secretory proteins as potential biomarkers of ovarian endometriosis. J Mol Diagnostics. 2015;17(3):325–34.
Malutan AM, Drugan T, Costin N, Ciortea R, Bucuri C, Rada MP, Mihu D. Pro-inflammatory cytokines for evaluation of inflammatory status in endometriosis. Cent Eur J Immunol. 2015;40(1):96–102.
Bakker R, Pierce S, Myers D. The role of prostaglandins E1 and E2, dinoprostone, and misoprostol in cervical ripening and the induction of labor: a mechanistic approach. Arch Gynecol Obstet. 2017;296(2):167–79.
Rahmioglu N, et al. World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonization Project: III. Fluid biospecimen collection, processing, and storage in endometriosis research. Fertil Steril. 2014;102(5):1233–43.
Dorien FO, El Aalamat Y, Waelkens E, De Moor B, D’Hooghe T, Fassbender A. Multiplex immunoassays in endometriosis: an array of possibilities. Front Biosci - Landmark. 2017;22:479–92.
Kim H, et al. Identification of serum biomarkers for diagnosis of endometriosis using multiplex immunoassays. Reprod Sci. 2020;27(5):1139–47.
Guo SW, Wang Y. The prevalence of endometriosis in women with chronic pelvic pain. Gynecol Obstet Invest. 2006;62(3):121–30.
Ciavattini A, et al. Uterine fibroids: pathogenesis and interactions with endometrium and endomyometrial junction. Obstet Gynecol Int. 2013;2013:173184.
Mihalyi A, et al. Non-invasive diagnosis of endometriosis based on a combined analysis of six plasma biomarkers. Hum Reprod. 2010;25(3):654–64.
Lebovic DI, Bentzien F, Chao VA, Garrett EN, Meng YG, Taylor RN. Induction of an angiogenic phenotype in endometriotic stromal cell cultures by interleukin-1β. Mol Hum Reprod. 2000;6(3):269–75.
Akoum A, Lawson C, McColl S, Villeneuve M. Ectopic endometrial cells express high concentrations of interleukin (IL)-8 in vivo regardless of the menstrual cycle phase and respond to oestradiol by up-regulating IL-1-induced IL-8 expression in vitro. Mol Hum Reprod. 2001;7(9):859–66.
Yu J, et al. IL-1β stimulates brain-derived neurotrophic factor production in Eutopic endometriosis stromal cell cultures: a model for cytokine regulation of neuroangiogenesis. Am J Pathol. 2018;188(10):2281–92.
Lee MY, Kim SH, Ihm HJ, Chae HD, Kim CH, Kang BM. Up-regulation of p21-activated kinase 1 by in vitro treatment with interleukin 1-beta and its increased expression in ovarian endometriotic cysts. Fertil Steril. 2011;96(2):508–11.
Pellicer A, Oliveira N, Ruiz A, Remohi J, Simon C. Exploring the mechanism(s) of endometriosis-related infertility: an analysis of embryo development and implantation in assisted reproduction. Hum Reprod. 1995;10(Suppl 2):91–7.
Simón C, Gutiérrez A, Vidal A, de los Santos MJ, Tarín JJ, Remohí J, Pellicer A. Outcome of patients with endometriosis in assisted reproduction: results from in-vitro fertilization and oocyte donation. Hum Reprod. 1994;9(4):725–9.
Zhihong N, Yun F, Pinggui Z, Sulian Z, Zhang A. Cytokine profiling in the eutopic endometrium of adenomyosis during the implantation window after ovarian stimulation. Reprod Sci. 2016;23(1):124–33.
Boomsma CM, Kavelaars A, Eijkemans MJC, Fauser BCJM, Heijnen CJ, MacKlon NS. Ovarian stimulation for in vitro fertilization alters the intrauterine cytokine, chemokine, and growth factor milieu encountered by the embryo. Fertil Steril. 2010;94(5):1764–8.
Acknowledgments
We would like to thank the physicians of the Reproductive Endocrinology and Minimally Invasive Gynecologic surgery divisions at the Cleveland Clinic for facilitating the involvement of their patients in this study. In particular, we would like to acknowledge Drs. Mark Dassel, Tommaso Falcone, Jeffrey Goldberg, Rosanne Kho, and Julierut Tantibhedyangkul. Additionally, we would like to acknowledge the Clinical and Translational Science Collaborative (CTSC) Bioanalyte Core of the Case Western Reserve University for their role in processing data samples.
Funding
Funding for this work was provided by a grant from the Cleveland Clinic Research Program Committee (#274).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Supplemental Figure 1
Mean cytokine and growth factor levels by endometriosis stage and cycle phase. P-values shown are for univariate analysis with Mann-Whitney test. Error bars represent standard error of the mean. Asterisk denotes statistically significant difference in luteal-phase and follicular-phase cytokine levels after adjustment for false discovery. (PDF 230 kb)
ESM 1
(DOCX 16 kb)
Rights and permissions
About this article
Cite this article
Llarena, N.C., Richards, E.G., Priyadarshini, A. et al. Characterizing the endometrial fluid cytokine profile in women with endometriosis. J Assist Reprod Genet 37, 2999–3006 (2020). https://doi.org/10.1007/s10815-020-01989-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10815-020-01989-y